Skip to main content

Health Bill (Fifth sitting)

Debated on Tuesday 23 June 2026

Column 165is located here

The Committee consisted of the following Members:

Chairs: † Sir Roger Gale, Dr Rupa Huq, Emma Lewell, Sir Jeremy Wright

Argar, Edward (Melton and Syston) (Con)

† Brackenridge, Sureena (Wolverhampton North East) (Lab)

Chambers, Dr Danny (Winchester) (LD)

† Daby, Janet (Lewisham East) (Lab)

† Foody, Emma (Cramlington and Killingworth) (Lab/Co-op)

† Irons, Natasha (Croydon East) (Lab)

† Johnson, Dr Caroline (Sleaford and North Hykeham) (Con)

† Joseph, Sojan (Ashford) (Lab)

† Kyrke-Smith, Laura (Aylesbury) (Lab)

† Morgan, Helen (North Shropshire) (LD)

† Prinsley, Peter (Bury St Edmunds and Stowmarket) (Lab)

† Robertson, Dave (Lichfield) (Lab)

† Robertson, Joe (Isle of Wight East) (Con)

† Smyth, Karin (Minister for Secondary Care)

† Stafford, Gregory (Farnham and Bordon) (Con)

† Twist, Liz (Blaydon and Consett) (Lab)

† White, Jo (Bassetlaw) (Lab)

Sanjana Balakrishnan, Rob Cope, Committee Clerks

† attended the Committee

Public Bill Committee

Tuesday 23 June 2026

[Sir Roger Gale in the Chair]

Health Bill

Clause 7 ordered to stand part of the Bill.

Clause 8

Directions to exercise Secretary of State’s functions

Question proposed, That the clause stand part of the Bill.

There is also a risk that such a provision will contribute to systemic pressures. The health service already absorbs a substantial proportion of public spending, and there are long-standing concerns about whether additional funding consistently produces the corresponding gains in efficiency or performance. A broadly defined power to provide financial assistance, unconstrained by detailed statutory controls, will reinforce that pattern, and may enable the continued allocation of funds without sufficient assurance that those funds are used in a disciplined and effective manner.

Column 181is located here

The clause’s reliance on what the Secretary of State, and I quote, “considers to be beneficial” further amplifies my concern, because that is an inherently subjective test. Without defined criteria, decisions may lack consistency and be even more difficult to scrutinise. Even where decisions are taken conscientiously—I would never suggest that the current Minister would do anything otherwise—the absence of clear standards will increase the risk of perceived unfairness or imbalance in the allocation of public resources.

There are also implications for existing funding and procurement frameworks. The health service operates through established mechanisms designed to promote fairness, competition and value for money. The broad power in this clause to provide direct financial assistance could cut across those arrangements by enabling selective support outside those structures. That may create inconsistencies between providers and reduce confidence in the integrity of any allocation process.

Column 182is located here

Column 187is located here

Clause 10 ordered to stand part of the Bill.

Clause 11

General power to direct integrated care boards

Currently, ICBs are accountable to NHS England. Under sections 14Z61 and 14Z62 of the National Health Service Act 2006, NHS England is able to direct an ICB when it has failed to carry out its functions, is failing, or is at risk of failure. If failure were to occur, NHS England can, among other things, direct another ICB to assume its functions. It can direct the ICB or its chief executive to carry out a function in a particular way or within a particular timeframe, or it can fire the ICB’s chief executive and direct the board on their replacement.

Clause 11 would replace those sections of the 2006 Act with new powers exclusively for the Secretary of State. It is important to note that those new powers are broader in scope. Not only does the Secretary of State gain the power to direct ICBs that are failing or at risk of failure, but, through a new general power, they will be able to direct ICBs to carry out their functions. The explanatory notes point to several benefits of that power. The Health Secretary will be able to exercise “oversight of ICBs” and could

“set standards that ICBs must meet when exercising their commissioning functions… Directions can capture a level of detail that could not be included in primary or secondary legislation”.

That is pertinent to clinical pathways for particular services. Directions could also reduce “unwarranted variation”, including by “ensuring nationally consistent standards”.

These changes could bring material benefits. If the Secretary of State—rather than an arm’s length body—has oversight, the Government could be more responsive to issues that emerge in the health system. The Department said in its memorandum to the Lords Delegated Powers and Regulatory Reform Committee that the new general power for the Health Secretary to direct ICBs is “necessary to ensure” that they are carrying out their functions correctly.

As we heard in the evidence session, there is variation in the system that leaves some patients in an unenviable position. James Cooper from Together for Short Lives said that

“19% of ICBs currently commission end-of-life care for children at home 24/7, provided by nurses and specialist consultants.”

What about the other 81%? Mr Cooper also said that ICBs were

“not taking on their full functions and implementing national guidance”,––[Official Report, Health Public Bill Committee, 16 June 2026; c. 44, Q72.]

and he was clear that he wanted more. I am curious to know why NHS England has failed on that, given that it does have some powers over ICBs. Is the issue that NHS England has been asleep at the wheel, or that its powers are not strong enough? Will the Minister share her thoughts on that?

I return to the philosophical contradiction in the Bill. This reorganisation was meant to be about devolving power away from the centre, yet power at the centre—with the Secretary of State—is being strengthened, because

ICBs, which are the devolved units in the system, are deemed to be underdelivering. From the Department’s perspective, is there such a thing as good and bad variation? It may be troubling to see that waiting times are better in some ICBs than in others, or that some ICBs commission around-the-clock end-of-life care for children when others do not, but is that not inevitable in a system in which commissioners are empowered to allocate resources based on an assessment of the needs of their own population? A decentralised system without variation surely cannot exist in the real world.

In their policy paper, “ICBs as strategic commissioners”, the Government are clear that they want to encourage ICBs to innovate and

“design new models of care”.

However, that will also create new variations across the health system. Those are not always bad, but I am not sure how the Government can achieve greater autonomy for ICBs, lower health inequalities and reduced variation across the system simultaneously, especially when the Secretary of State has strong powers to intervene. There is a lack of coherence, and at least one objective will surely have to give. There is a difference between taking back control and taking control of absolutely everything.

I recognise that there are safeguards in clause 11 against the Health Secretary making directions relating to the employment or treatment of a particular individual. Likewise, the Secretary of State will not be able to issue directions that contravene National Institute for Health and Care Excellence guidance. Those are sensible guardrails, but they do not go far enough.

Clause 11 gives the Secretary of State power to fire and hire ICB leaders as he sees fit. Should a political office holder be able to wield such power? NHS England was operationally independent, but the Secretary of State is not. This Government have shown themselves to be highly political on health, not least by not taking any reorganisation advice from Lord Darzi, but also on clinical matters such as puberty blocker trials and their shambolic handling and delaying of the RSV vaccinations. The Secretary of State must be able to act if an ICB is failing, but should the power to fire and hire healthcare leaders be in the hands of politicians?

I remind Members what Jon Restall of Managers in Partnership said in our evidence session. His verdict on the Bill was:

“On the whole, it is probably more of a centralising measure.” ––[Official Report, Health Public Bill Committee, 16 June 2026; c. 79, Q122.]

When we discussed clause 8, I highlighted the risk of a chilling effect. If ICBs are operating under the spectre of political intervention, they are less likely to engage in the innovation and risk taking that Ministers seem to want. If ICB leaders step out of line by doing something that the Government dislike, they do not just face interference or micromanagement; they are staring at a P45. We have sought to address that by tabling amendment 47, which would amend clause 11 so that the Secretary of State did not have the power to remove the chief executive of an ICB.

The former Health Secretary, my right hon. Friend the Member for Godalming and Ash (Sir Jeremy Hunt), said that the health system has too many targets. In our evidence session, he said that abolishing NHS England makes sense only if the intention is not to increase

control and impose more targets. The centre is responsible for 18 monthly operational targets for hospitals and 44 quality and outcomes frameworks for GPs. My right hon. Friend wrote yesterday in a newspaper:

“Every new health secretary is told by No 10 to ‘grip’ the service. Every time, the response is a new target.

The result is learned helplessness… They are micro-managed to deliver ‘improvement trajectories’, leaving them little time for the innovations that boost productivity.”

That is a sobering assessment. It is why Members should be concerned that clause 11 paves the way for more command and control issued from Whitehall.

Once organisations are judged by certain metrics, they, not the broader quality of service provided, become the primary objective. As is often said, when a measure becomes a target, it may cease to be a good measure. Could the Minister reassure Members that the Health Secretary’s new powers of direction will not be used to lay additional targets upon additional targets on providers?

The powers in the Bill for taking control of everything risk the creation of a politicised service in which those who shout the loudest get preferential treatment. Several groups have indicated their desire for the Secretary of State to issue directions to reduce variation in service, but what about those we have not heard from? We have debates in the House about screening for some conditions and treatment of others. What about all the conditions we do not hear about—the ones that do not have a celebrity campaign behind them?

How many Members on the Government Benches have heard of corticobasal degeneration, Wiskott-Aldrich syndrome, Lafora body disease, Friedreich’s ataxia or maple syrup urine disease? Are ICBs failing to deliver appropriate care for people with those conditions? Who is publishing the data for us to know? How will we ensure that celebrity campaign groups to the Secretary of State do not distort the priorities of the health service, which should be clinical need, not the ability to pay or have a celebrity shout for you? If the Minister is not able to answer the question today, would she be willing to write to me on that matter?

The Government set about abolishing NHS England with a vision to devolve power away from the centre. It was a laudable vision that the Opposition were willing to row in behind, but the legislation before us is far from that vision. The Government are giving more responsibility to ICBs and expecting more from them, while at the same time giving the Health Secretary more powers to micromanage them, all while under immense pressure to cut their running costs by 50%.

In a report published on 1 May, the NHS Alliance said:

“Trust and ICB respondents indicated that we are likely to see an increase in services being reduced or closed this year. More than a third (35 per cent) stated that their organisation cut services in 2025/26, with 64 per cent saying they expect to do this in 2026/27.”

The Government are cooking up a disaster. More responsibilities, more micromanagement, less money and cuts to frontline services—that is not what the Government promised, nor the vision they described, but it appears to be what they have achieved.

I am sure this will elicit a smile from the Minister, but once again I remind her of past comments. During the passage of the Health and Social Care Act, she said:

Column 192is located here

“Politically we might disagree with the centralisation of the NHS and the diktat as opposed to the permissiveness. I am definitely on the more localised, permissive side.”—[Official Report, 14 September 2021; Vol. 700, c. 223.]

On another occasion, speaking again on the legislation, the Minister said:

“As I said in Committee, this is fundamentally another NHS reorganisation Bill. It is a restructuring of the NHS and a centralisation of power within the NHS. It does not nothing to achieve integration and nothing to improve accountability to the public, to patients and to communities… It is clear that centralising control in the NHS is very much the wrong approach. Local representatives need much more power over local services, and accountability needs to be much better at a local level.”—[Official Report, 30 March 2022; Vol. 711, c. 941.]

I appreciate that Ministers may be frustrated after the election, pulling levers only to find that they are not attached where they thought they were, or even to anything at all, but I find it hard to reconcile what Ministers previously said, given the strength and universality of those comments, with what they have sought to do in this Bill.

I understand the Government’s intention in clause 11, but it is unnecessarily sweeping. Ministers promised to let go of the steering wheel, but in practice they have installed a larger one. The hon. Member for North Shropshire hit the nail on the head when speaking during the Bill’s Second Reading:

“This Bill focuses on shuffling responsibility around Whitehall and gives the Secretary of State the role of chief micromanager.” —[Official Report, 1 June 2026; Vol. 786, c. 909.]

The gap between what was promised and what is being offered has left the British public wondering: did the Labour Government really believe that power was too concentrated, or that power was concentrated in the wrong hands? I hope the Minister will enlighten us.

Clause 11 ordered to stand part of the Bill.

Ordered, That further consideration be now adjourned. —(Emma Foody.)

Adjourned till Thursday 25 June at half-past Eleven o’clock.

Written evidence reported to the House

HB61 Just Fair

HB62 Provider Public Health Network

HB63 Nuffield Trust

HB64 Dr Mary Guy, Research Fellow, Trinity College Dublin

HB65 Association of Anaesthetists

HB66 Sickle Cell Society

HB67 Healthwatch England (supplementary submission)

HB68 Henry Burkitt, Managing Director, Oxygen Strategy (re: clause 58 (NICE compliance period))

Column 200is located here

HB69 A coalition of six homelessness charities: St. Mungo’s, Homeless Link, Groundswell, Single Homeless Project, Crisis and Pathway

HB70 Healthwatch York

HB71 Patient Experience Library

HB72 Association of Optometrists

HB73 Care Quality Commission (CQC)

HB74 Healthwatch Redbridge

HB75 Royal College of Paediatrics and Child Health

HB76 National Children’s Bureau on behalf of the Health Policy Influencing Group (HPIG)

HB77 Specialised Healthcare Alliance (SHCA)

HB78 The College of Optometrists